blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3969122

EP3969122 - METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  18.02.2022
Database last updated on 03.01.2025
FormerThe international publication has been made
Status updated on  20.11.2020
Most recent event   Tooltip10.07.2024Amendment by applicant 
Applicant(s)For all designated states
Whitehead Institute For Biomedical Research
455 Main Street
Cambridge, MA 02142 / US
[2022/12]
Inventor(s)01 / YOUNG, Richard A.
4 Longfellow Pl
Boston, MA 02114 / US
02 / BOIJA, Ann
255 Beacon St
Somerville, MA 02143 / US
03 / KLEIN, Isaac
42 School St
Milton, MA 02186 / US
 [2022/12]
Representative(s)Lock, Graham James, et al
Fry Heath & Spence LLP
Unit A, Faraday Court
Faraday Road
Crawley, West Sussex RH10 9PU / GB
[2022/12]
Application number, filing date20806845.215.05.2020
[2022/12]
WO2020US33295
Priority number, dateUS201962848539P15.05.2019         Original published format: US 201962848539 P
US201962927073P28.10.2019         Original published format: US 201962927073 P
[2022/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020232416
Date:19.11.2020
Language:EN
[2020/47]
Type: A1 Application with search report 
No.:EP3969122
Date:23.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 19.11.2020 takes the place of the publication of the European patent application.
[2022/12]
Search report(s)International search report - published on:US19.11.2020
(Supplementary) European search report - dispatched on:EP18.12.2023
ClassificationIPC:A61P35/00, G01N33/50, G01N33/68, C12Q1/6806
[2023/42]
CPC:
G01N33/5011 (EP,IL,US); A61K31/704 (KR); A61P35/00 (EP,IL,KR);
A61P35/04 (KR); C12Q1/6806 (EP,IL); C12Q1/6841 (US);
G01N33/6875 (EP,IL); C12Q2565/113 (IL); C12Q2600/158 (US);
G01N2500/02 (US) (-)
C-Set:
C12Q1/6806, C12Q2565/113 (EP)
Former IPC [2022/12]A61P35/00, G01N33/50, G01N33/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/12]
TitleGerman:VERFAHREN ZUR CHARAKTERISIERUNG UND VERWENDUNG VON MITTEL-KONDENSAT-WECHSELWIRKUNGEN[2022/12]
English:METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS[2022/12]
French:PROCÉDÉS DE CARACTÉRISATION ET MÉTHODES D'UTILISATION D'INTERACTIONS AGENT-CONDENSAT[2022/12]
Entry into regional phase15.12.2021National basic fee paid 
15.12.2021Search fee paid 
15.12.2021Designation fee(s) paid 
15.12.2021Examination fee paid 
Examination procedure15.12.2021Examination requested  [2022/12]
09.07.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
27.05.2022Renewal fee patent year 03
30.05.2023Renewal fee patent year 04
28.05.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2019183552  (WHITEHEAD INST BIOMEDICAL RES [US]) [XP] 1-10 * paragraphs [0018] , [0 26] - [0029] - [0 32] , [0 40] , [ 181]; example 6 *;
 [XP]WO2020078924  (MAX PLANCK GESELLSCHAFT [DE]) [XP] 1-10 * paragraphs [0007] , [0008] , [0208] , [ 211] - [0212] - [ 220] *;
 [A]  - BENJAMIN R. SABARI ET AL, "Coactivator condensation at super-enhancers links phase separation and gene control", SCIENCE, US, (20180727), vol. 361, no. 6400, doi:10.1126/science.aar3958, ISSN 0036-8075, page eaar3958, XP055728060 [A] 1-10 * pages 4-5 *

DOI:   http://dx.doi.org/10.1126/science.aar3958
International search[Y]WO0238734  (CISTEM MOLECULAR CORP [US], et al) [Y] 91 * entire document *;
 [X]US2007054353  (WHITE JOHN [CA], et al) [X] 72, 73, 80, 81 * entire document *;
 [X]US2007178537  (CHIOSIS GABRIELA [US], et al) [X] 33-35 * entire document *;
 [X]US2014121122  (LI XIANQIANG [US]) [X] 1, 2, 4, 5 * entire document *;
 [XY]US2014242602  (CHIOSIS GABRIELA [US], et al) [X] 98-100 * entire document * [Y] 90, 105;
 [XY]US2016348180  (AL-MURRANI SAMER [US]) [X] 97, 101, 102 * entire document * [Y] 103-105;
 [X]US2018133168  (HONG JIN-TAE [KR], et al) [X] 55, 56, 64, 65 * entire document *;
 [XY]US2018313827  (BALDWIN ANDREW [GB], et al) [X] 37-42, 45-50, 88, 89, 92, 93 * entire document * [Y] 90, 91, 103, 104;
 [PA]WO2019183552  (WHITEHEAD INST BIOMEDICAL RES [US]) [PA] 1, 2, 4, 5, 33-35, 37-42, 45-50, 55, 56, 64, 65,72, 73, 80, 81, 88-93, 97-105* entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.